Dexcom is teaming up with its thousands of global brand advocates – Dexcom Warriors and Stelo Ambassadors, including Nick Jonas, Lance Bass, Retta, Ed Gamble, Molly Sandén and more – to inspire and ...
SAN DIEGO--(BUSINESS WIRE)-- This World Diabetes Day, DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing technology, is encouraging people with diabetes globally to take the first ...
Shay Speakman-Brown, Dexcom Head of Market Access discusses diabetes management. The views expressed here are not necessarily those of The Scotsman and it is recommended to always seek NHS advice ...
Q3 2025 Management View Interim CEO Jacob Leach reported "third quarter organic revenue growth of 20% compared to the third quarter of 2024" and highlighted "solid share performance in both our U.S.
Tidepool today announced a strategic collaboration with Oura to support a groundbreaking dataset for diabetes research.
DexCom (DXCM) is forecasting robust earnings growth of 19.2% per year and revenue growth of 11.8% per year. Both figures outpace the broader US market’s revenue growth forecast of 10.4%. Over the past ...
Dexcom is facing scrutiny and class-action lawsuits over alleged safety and accuracy issues with its G7 monitor.
Shares of the medical-device maker DexCom (NASDAQ: DXCM) are down by 37% this year. The diabetes-focused healthcare company disappointed investors with its second-quarter results, leading to a massive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback